The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes

被引:83
|
作者
Noble, JA
Valdes, AM
Thomson, G
Erlich, HA
机构
[1] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA
[2] Roche Mol Syst, Dept Human Genet, Alameda, CA USA
[3] Childrens Hosp Oakland, Inst Res, Oakland, CA USA
关键词
D O I
10.2337/diabetes.49.1.121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HLA-DPB1 genotypes were determined for samples from 269 multiplex Caucasian families from the Human Biological Data Interchange. DRB1 and DQB1 loci were also characterized, allowing assignment of DPB1 alleles to haplotypes and calculation of linkage disequilibrium values. Frequencies for several DPB1 alleles differed significantly between patients and affected family-based control subjects. Some differences were attributable to linkage disequilibrium with DR and DQ alleles, whereas others were not. DPB1*0301 and DPB1*0202 alleles are predisposing for type 1 diabetes in these data, not only in analyses of individual alleles, but also in genotype analyses. DPB1*0402 appears protective; however, stratification analysis indicates that its protective effect is specific for DR3 haplotypes. A protective role for DPB1*0401 is suggested by genotype analysis. For increased statistical power, DPB1 alleles were pooled into three categories: susceptible, neutral, and protective after removal of effects due to linkage disequilibrium with DR-DQ. Analysis of these pools suggests that DPB1 primarily affects susceptibility to, rather than protection from, type 1 diabetes in a dominant fashion. This effect is more apparent in patients with genotypes other than the highest risk DR3/DR4-DQB1*0302 genotype. These data support a role for the DPB1 locus in conferring susceptibility to type 1 diabetes.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条
  • [1] Modeling of HLA class II susceptibility to type I diabetes reveals an effect associated with DPB1
    Valdes, AM
    Noble, JA
    Génin, E
    Clerget-Darpoux, F
    Erlich, HA
    Thomson, G
    [J]. GENETIC EPIDEMIOLOGY, 2001, 21 (03) : 212 - 223
  • [2] DPB1*TF a novel HLA class II DPB1 allele (DPB1*6701) identified in a Turkish family
    Meyer, CG
    May, J
    Simon, C
    Bohm, BO
    Loeliger, CC
    [J]. TISSUE ANTIGENS, 1996, 48 (03): : 231 - 232
  • [3] DPB1*BR: An Mhc class II DPB1 allele (DPB1*6601) of negroid origin
    Schnittger, L
    May, J
    Kretschmer, C
    Kremsner, PG
    Meyer, CG
    [J]. IMMUNOGENETICS, 1996, 44 (05) : 405 - 406
  • [4] HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity
    Rosenman, K. D.
    Rossman, M.
    Hertzberg, V.
    Reilly, M. J.
    Rice, C.
    Kanterakis, E.
    Monos, D.
    [J]. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2011, 68 (07) : 487 - 493
  • [5] HLA loci other than DR and DQ can influence susceptibility to type I diabetes: Analysis of DPB1 and HLA-A in 269 Caucasian, multiplex families
    Noble, JA
    Valdes, AM
    Apple, RJ
    Bugawan, TL
    Thomson, G
    Erlich, HA
    [J]. DIABETES, 1998, 47 : A395 - A395
  • [6] Identification of a novel DPB1*allele (DPB1*6901) and the occurrence of HLA haplotypes that extend to DPB1
    Varney, MD
    Tait, BD
    [J]. TISSUE ANTIGENS, 2000, 55 (02): : 188 - 190
  • [7] HLA class II haplotype and DPB1 effects in multiplex IDDM families
    Noble, JA
    Valdes, AM
    Cook, M
    Klitz, W
    Thomson, G
    Erlich, HA
    [J]. HUMAN IMMUNOLOGY, 1996, 47 (1-2) : O824 - O824
  • [8] The HLA class I A locus affects susceptibility to type 1 diabetes
    Noble, JA
    Valdes, AM
    Bugawan, TL
    Apple, RJ
    Thomson, G
    Erlich, HA
    [J]. HUMAN IMMUNOLOGY, 2002, 63 (08) : 657 - 664
  • [9] HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes
    Johansson, S
    Lie, BA
    Pociot, F
    Nerup, J
    Cambon-Thomsen, A
    Kockum, I
    Thorsby, E
    Undlien, DE
    [J]. TISSUE ANTIGENS, 2003, 61 (05): : 344 - 351
  • [10] DPB1 Alleles are associated with type 1 diabetes susceptibility in multiple ethnic groups
    Cruz, TD
    Valdes, AM
    Santiago, A
    de Llado, TF
    Raffel, LJ
    Zeidler, A
    Rotter, JI
    Erlich, HA
    Rewers, M
    Bugawan, T
    Noble, JA
    [J]. DIABETES, 2004, 53 (08) : 2158 - 2163